Complete Wegovy vs Mounjaro Price Comparison Guide
Wegovy Compared to Mounjaro: UK's Most Competitive Pricing Structure
When evaluating Wegovy compared to Mounjaro costs across the UK market, EverydayMeds consistently offers the lowest transparent pricing without hidden fees. Our Wegovy single pen prices start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. This clear pricing structure eliminates the confusion many patients experience when comparing providers who bundle consultation fees separately.
Mounjaro pricing follows a similar transparent approach, though the dose escalation schedule differs due to tirzepatide's dual GIP and GLP-1 receptor mechanism. Both medications represent significant monthly investments, but our bundle options—such as the Intro Trio at £299.99 covering your first 12 weeks of Wegovy—provide better value than purchasing individual pens. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive rates.
Wegovy Compared to Mounjaro: Bundle Savings and Payment Flexibility
Understanding the financial commitment when evaluating Wegovy compared to Mounjaro requires looking beyond single pen costs to long-term treatment expenses. Our 2-pen Getting Started bundles offer convenience and supply security—the Wegovy Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of treatment with assured cold-chain delivery. Similarly, our Progress Duo (0.5mg & 1mg) at £189.99 supports weeks 5-12 of your weight management journey.
For patients reaching maintenance doses, the Ultimate Stability Trio provides three months of 2.4mg Wegovy pens for £649.99, ensuring treatment continuity without monthly reordering. This pricing transparency extends to our Mounjaro offerings, where comparable bundle structures support different dose escalation schedules. Both treatments require identical clinical assessments through our GPhC-registered pharmacy (#9012878), ensuring fair comparison of total treatment costs.
Clinical Evidence: Wegovy Compared to Mounjaro Trial Results
When examining Wegovy compared to Mounjaro clinical evidence, both demonstrate significant efficacy in clinical trials, though direct head-to-head comparisons require caution due to different trial designs and populations. Wegovy's STEP trial programme showed that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. The STEP 5 trial demonstrated sustained clinically studied weight loss at 2 years, while the recent SELECT trial revealed a 20% reduction in major cardiovascular events.
Mounjaro's clinical programme demonstrates the potential benefits of dual GIP and GLP-1 receptor activation, though comparing percentage weight loss directly between trials would be inappropriate given different methodologies and endpoints. Both prescription-only medicines work alongside reduced-calorie diets and increased physical activity, representing proven approaches to weight management when lifestyle modifications alone prove insufficient.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy compared to Mounjaro mechanisms helps inform treatment selection beyond price considerations alone. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural glucagon-like peptide-1 hormone. This hormone normally signals satiety after eating, but Wegovy's synthetic version provides sustained appetite regulation throughout the week. The medication may help reduce food cravings by acting on brain appetite centres, promoting feelings of fullness after smaller meals. Administered through Novo Nordisk's FlexTouch pen system, Wegovy requires once-weekly subcutaneous injection, typically in the thigh, upper arm, or abdomen. The dose escalation from 0.25mg to 2.4mg over 16 weeks allows your body to adjust gradually while minimising potential side effects.
EverydayMeds Ordering Process: Assessment to Delivery
Obtaining Wegovy compared to Mounjaro through EverydayMeds follows an identical streamlined process designed for convenience and clinical safety. Our 3-minute online clinical assessment captures essential medical history, current medications, and weight management goals to support prescriber decision-making. Qualified prescribers review applications within 3 working days as standard, or 24 hours with our express service, ensuring thorough evaluation rather than rushed approvals. Once prescribed, your chosen medication ships via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity from our GPhC-registered facility (#9012878). This process applies equally whether you're starting with Wegovy's 0.25mg dose or beginning Mounjaro treatment, ensuring consistent clinical standards. Payment processing occurs only after prescription approval, protecting you from charges if treatment proves unsuitable.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical differences between Wegovy compared to Mounjaro extend beyond pricing to real-world usage considerations. Both require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge. Mounjaro provides only 21 days room temperature storage, potentially limiting holiday or business travel. Wegovy's FlexTouch pen system delivers precise dosing with an audible click confirmation, while both medications require weekly injection site rotation to prevent lipodystrophy. The dose escalation schedules differ—Wegovy follows a 16-week progression to 2.4mg maintenance, while Mounjaro's tirzepatide requires different timing due to its dual receptor mechanism. Both treatments are prescription-only medicines requiring ongoing clinical monitoring throughout treatment.
Wegovy Compared to Mounjaro: UK Market Price Analysis
Comprehensive market analysis reveals significant price variations when evaluating Wegovy compared to Mounjaro across UK providers, making transparent pricing essential for informed decisions. Many clinics advertise low headline prices but add consultation fees, delivery charges, or mandatory add-on services that inflate total costs substantially. EverydayMeds' all-inclusive pricing eliminates these surprises—our £79.99 Wegovy starter includes clinical assessment, prescriber review, and next-day delivery without additional charges.
Regional price disparities often reflect different business models rather than medication quality differences, as all legitimate UK suppliers source identical Novo Nordisk products. Private clinic consultations can cost £200-400 before medication expenses, while some online providers charge separate fees for prescriber time, delivery, or customer support. Our bundle options provide additional value—the Gentle Start Trio at £269.99 offers extended 0.25mg dosing for patients requiring slower escalation, a flexibility rarely available elsewhere at comparable prices.
Complete Treatment Investment: Beyond Initial Costs
Evaluating long-term treatment costs represents the most critical aspect when choosing Wegovy compared to Mounjaro, as both treatments typically require extended use for sustained benefits. Clinical evidence suggests weight regain occurs when treatment stops—STEP 1 extension data showed patients regained approximately two-thirds of lost weight within one year of discontinuation, emphasising weight management as a long-term commitment. Monthly maintenance costs at 2.4mg Wegovy approximate £209.99, while our Ultimate Stability Trio reduces this to £216.66 per month through bulk purchasing. Mounjaro maintenance pricing follows similar patterns, though dose requirements may differ based on individual response and tolerability.
Insurance coverage remains limited for weight management medications in the UK, making out-of-pocket affordability crucial for treatment continuity. NICE TA875 recommends Wegovy within specialist weight management services, but NHS availability remains restricted despite proven cardiovascular benefits demonstrated in the SELECT trial. Private treatment through regulated providers like EverydayMeds ensures access while maintaining clinical oversight, with our returning customer code DOSE25 providing ongoing savings recognition for treatment commitment.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds at the UK's most competitive prices, with your prescriber helping determine which treatment suits your individual circumstances best. Our transparent pricing, comprehensive clinical assessments, and commitment to ongoing support ensure you receive appropriate care throughout your weight management journey. New customers save immediately with code FIRST40, while our express prescriber reviews mean you could start treatment within 24 hours of application. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, or explore our complete range of weight management treatments. Remember, these are prescription-only medicines requiring professional medical oversight—our qualified team ensures you receive safe, effective treatment tailored to your specific needs and medical history.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
